Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) remains a major global health burden with limited therapeutic options. Heat shock factor 2 binding protein (HSF2BP), originally characterized as a germ cell-specific regulator of meiosis, is significantly upregulated in both MASLD patient livers and high-fat diet (HFD)-fed mice. Here, we identify HSF2BP as a key metabolic regulator in hepatocytes that alleviates hepatic lipid accumulation by enhancing mitochondrial function.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Xiaoning Wu
Immunomodulatory effects of nerve stimulator-guided brachial plexus block with laryngeal mask general anesthesia in pediatric upper limb surgery
Abstract Background: Pediatric surgical trauma can trigger the body's stress response, leading to immune dysfunction and affecting postoperative recovery. At present, nerve stimulator-guided brachial plexus block has been widely used in children, but its effect on immune function combined with laryngeal mask general anesthesia remains to be clarified.
Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic Recompensation—Authors' Reply
We sincerely thank Hofer and colleagues for their insightful commentary [1] on our study describing the concept of ‘unstable recompensation’ in hepatitis B virus (HBV)-related decompensated cirrhosis [2]. Their letter thoughtfully underscores the evolving paradigm of hepatic recompensation as a dynamic process, wherein serial assessment of laboratory markers provides superior prognostic information compared with static baseline evaluations.
Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic Recompensation—Authors' Reply
We sincerely thank Hofer and colleagues for their insightful commentary [1] on our study describing the concept of ‘unstable recompensation’ in hepatitis B virus (HBV)-related decompensated cirrhosis [2]. Their letter thoughtfully underscores the evolving paradigm of hepatic recompensation as a dynamic process, wherein serial assessment of laboratory markers provides superior prognostic information compared with static baseline evaluations.
Editorial: Caught in the Middle—Exploring the Grey Zone Between Decompensated and Recompensated HBV‐Related Cirrhosis. Authors' Reply
We sincerely thank Professors Tsai and Fallahzadeh for their thoughtful editorial [1], ‘Caught in the Middle – Exploring the Grey Zone between Decompensated and Recompensated HBV-Related Cirrhosis’ on our recent publications [2]. Their insightful comments highlight the evolving understanding of hepatic recompensation and the complexity of the transition between decompensated and recompensated stages in chronic liver disease.
Sevoflurane blocks KLF5‐mediated transcriptional activation of ITGB2 to inhibit macrophage infiltration in hepatic ischemia/reperfusion injury
Sevoflurane (Sevo) preconditioning and postconditioning play a protective role against injury induced by hepatic ischemia/reperfusion (I/R). At the same time, the involvement of macrophage infiltration in this process and the precise mechanisms are unclear. Here, we designed this research to elucidate the protective effects of Sevo against hepatic I/R injury and the molecules involved.
Current practices and challenges in application of trauma‐informed care for accidentally injured patients: An exploratory qualitative study
1 INTRODUCTION Data analysis concerning fatal diseases across 195 countries and regions reveals that approximately 31.399 million deaths were attributable to accidents, including events such as traffic collisions and drownings. Notably, traffic accidents accounted for 13.35 million of these deaths, placing them as the sixth leading cause of death globally (Roth et al., 2018).
Persistent steatosis correlates with decreased fibrosis regression during anti‐HBV treatment in patients with chronic HBV infection
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest. Supporting Information Filename Description jmv29156-sup-0001-Supplementary_Appendixes.docx21.1 KB Supporting information. jmv29156-sup-0002-Supplementary_Figure_1.tif13.7 MB Supporting information. jmv29156-sup-0003-Supplementary_Figure_2.tif18.2 MB Supporting information. jmv29156-sup-0004-Supplementary_Figure_3.tif25.4 MB Supporting information.
Development of a questionnaire for measuring trauma
Back to Journals » Journal of Multidisciplinary Healthcare » Volume 17 Authors Xia W , Wang Y, Wu X, Yang X Received 27 September 2023 Accepted for publication 11 January 2024 Published 25 January 2024 Volume 2024:17 Pages 367—378 DOI https://doi.org/10.2147/JMDH.S437341 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Scott Fraser Weiping Xia,1,2 Yanbo Wang,1 Xiaoning Wu,1 Xiaojie Yang3 1Clinical Research Center...
Angular momentum and memory effect
Abstract It is a long-standing problem in general relativity that the notion of angular momentum of an isolated system has supertranslation ambiguity. In this paper, we argue that the ambiguity is essentially because of the gravitational wave memory. When properly subtracting the memory effect of the observer, one can introduce a supertranslation invariant definition of the angular momentum at null infinity even for dynamical process.
Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction
Tumor Biology and Immunology Guillaume Rieunier, Xiaoning Wu, Letitia E. Harris, Jack V. Mills, Ashwin Nandakumar, Laura Colling, Elena Seraia, Stephanie B. Hatch, Daniel V. Ebner, Lisa K. Folkes, Ulrike Weyer-Czernilofsky, Thomas Bogenrieder, Anderson J. Ryan and Valentine M.
Targeting IGF perturbs global replication through ribonucleotide reductase dysfunction
Research Article Guillaume Rieunier, Xiaoning Wu, Letitia E. Harris, Jack V. Mills, Ashwin Nandakumar, Laura Colling, Elena Seraia, Stephanie B. Hatch, Daniel V. Ebner, Lisa K. Folkes, Ulrike Weyer-Czernilofsky, Thomas Bogenrieder, Anderson J. Ryan and Valentine M. Macaulay DOI: 10.1158/0008-5472.CAN-20-2860 Abstract Inhibition of IGF receptor (IGF-1R) delays repair of radiation-induced DNA double-strand breaks (DSB), prompting us to investigate whether IGF-1R influences endogenous DNA damage.
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir
The full text of this article hosted at iucr.org is unavailable due to technical difficulties.
Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage
Molecular Cell Biology Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage Tamara Aleksic, Nicki Gray, Xiaoning Wu, Guillaume Rieunier, Eliot Osher, Jack Mills, Clare Verrill, Richard J. Bryant, Cheng Han, Kathryn Hutchinson, Adam G. Lambert, Rajeev Kumar, Freddie C. Hamdy, Ulrike Weyer-Czernilofsky, Michael P. Sanderson, Thomas Bogenrieder, Stephen Taylor and Valentine M. Macaulay
Nuclear IGF-1R interacts with regulatory regions of chromatin to promote RNA polymerase II recruitment and gene expression associated with advanced tumor stage
Nuclear IGF-1R interacts with regulatory regions of chromatin to promote RNA polymerase II recruitment and gene expression associated with advanced tumor stage Tamara Aleksic, Nicki E Gray, Xiaoning Wu, Guillaume Rieunier, Eliot Osher, Jack Mills, Clare Verrill, Richard J Bryant, Cheng Han, Kathryn Hutchinson, Adam Lambert, Rajeev Kumar, Freddie C.
Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapy
A total of 183 patients with paired liver biopsies were enrolled. After excluding unqualified biopsies, 162 patients with sufficient pre- and post-treatment liver specimens were included in the final analysis. All specimens were assessed by Ishak modified HAI grading and fibrosis staging and SHG/TPEF-based qFibrosis (Fig. 1). Patients were predominantly male (78%) with a median age of 36 years, median baseline HBV DNA of 6.80 Log IU/mL and ALT level of 81.4 U/L.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Xiaoning
Contact Xiaoning, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack